ASCO-GU 2018: Phase Ib study of concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with urothelial cancer of the bladder: BTCRC-GU15-023 study.

Trials Conferences Products Companies Influencers Key Population ^BETA

menu

Back

Copyright © LARVOL 2025. All rights reserved.

Privacy Policy
Terms of Service

clear

Trials

Conferences

Products

Companies

Influencers

Key Population ^BETA

Feedback

Privacy Policy

Terms of Service